What is SomaLogic?
SomaLogic operates at the forefront of proteomics, offering a platform designed for robust, high-throughput proteomic analysis. Its technology provides broad proteome coverage, low limits of detection, high reproducibility, and cost-effectiveness. This advanced capability positions SomaLogic as a key player in enabling deeper biological insights for research, diagnostics, and therapeutic development. The company's focus on delivering comprehensive proteomic data supports advancements across various healthcare and life science applications.
How much funding has SomaLogic raised?
SomaLogic has raised a total of $1.3B across 11 funding rounds:
Private Equity
$10M
Unspecified
$1M
Private Equity
$16.5M
Private Equity
$60.5M
Private Equity
$163M
Private Equity
$44.9M
Private Equity
$200M
Debt
$2M
Series A
$214M
Stock Offering
$630M
Private Equity (2013): $10M, investors not publicly disclosed
Unspecified (2014): $1M supported by Bill & Melinda Gates Foundation
Private Equity (2014): $16.5M, investors not publicly disclosed
Private Equity (2016): $60.5M backed by Visium Healthcare Partners
Private Equity (2016): $163M, investors not publicly disclosed
Private Equity (2017): $44.9M, investors not publicly disclosed
Private Equity (2018): $200M supported by Quest Diagnostics, Nan Fung Life Sciences, iCarbonX, Madryn Asset Management, Otsuka Pharmaceutical, ProQuest Investments, and Visium Healthcare Partners
Debt (2020): $2M featuring PPP
Series A (2020): $214M backed by Madryn Asset Management, Monashee Investment Management, Millennium Management, Logos Capital, Janus Henderson Group, Farallon Capital Management, Fiscus Ventures, Casdin Capital, Ziff Capital Healthcare Ventures, Soleus Capital, T. Rowe Price Associates, Mossrock Capital, Boston Millennia Partners, Revelation Partners, Foresite Capital, Remagine Ventures, Blue Water Life Science Advisors, and Redmile Group
Stock Issuance/Offering (2021): $630M with participation from Casdin Capital, Corvex Management, Janus Henderson Group, SB Management, and T. Rowe Price
Key Investors in SomaLogic
Madryn Asset Management
Madryn Asset Management is a leading alternative asset management firm that invests in innovative and unique healthcare companies.
Casdin Capital
Casdin Capital, LLC was founded in 2011 and brings a deep understanding, expertise and long-term perspective to financing the next generation of life science innovation. Specific only to the firm's diagnostics and molecular information portfolio, Casdin Capital has invested in many of the leading pioneers, including but not limited to Foundation Medicine, Invitae, Adaptive Biotechnologies, Flatiron Health and 23andMe. In addition, Eli Casdin currently serves on the board of directors of Exact Sciences, a leader in the field of molecular screening for cancer.
Janus Henderson Group
Janus Henderson is a global investment management firm that provides a broad range of investment solutions and advisory services to institutional investors, financial professionals, and individual clients. The company is focused on helping clients achieve their financial objectives through disciplined investment strategies, in-depth research, and a commitment to delivering strong long-term outcomes. By combining global market expertise with a client-centric approach, it seeks to create investment solutions that address diverse financial goals and evolving market conditions.
What's next for SomaLogic?
With substantial enterprise-level and strategic investments, SomaLogic is poised for accelerated growth and expansion. The company's robust funding will likely fuel further development of its proteomics platform, enhance its market penetration, and support strategic partnerships. Future initiatives may include scaling operations, advancing its technology pipeline, and exploring new applications for its proteomic insights. The consistent flow of capital indicates strong investor confidence in SomaLogic's long-term vision and its capacity to drive innovation in precision medicine and biological discovery.
See full SomaLogic company page
